Global ECMO Devices Market Growth 2025-2031

Global ECMO Devices Market Growth 2025-2031

The global ECMO Devices market size is predicted to grow from US$ 249 million in 2025 to US$ 312 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Market Drivers:

Rising Incidence of Cardiopulmonary Disorders:

Increasing cases of respiratory and cardiac diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and acute respiratory distress syndrome (ARDS), drive demand for ECMO devices. These devices are essential for patients whose heart and lungs need support, especially during severe cases or surgeries.

Advancements in ECMO Technology:

Innovations like portable ECMO devices, improved oxygenators, and better control systems have enhanced the safety and effectiveness of ECMO therapy, expanding its applications and encouraging adoption in a broader range of healthcare settings.

Increasing Use in COVID-19 and Critical Care:

The COVID-19 pandemic highlighted the need for advanced respiratory support for patients with severe respiratory failure. ECMO became a critical intervention in some severe cases, increasing awareness and demand for these devices.

Growing Use in Pediatric and Neonatal Care:

ECMO devices are increasingly being used in neonatal and pediatric ICUs to support infants with congenital heart disease or respiratory failure, expanding the market across different age groups.

Rising Number of Specialized Healthcare Facilities:

The increase in specialized healthcare centers, especially in developed economies, has made ECMO therapy more accessible, as these devices are often only available in well-equipped, high-acuity centers.

Market Challenges:

High Cost of ECMO Therapy and Devices:

ECMO treatment and the devices themselves are expensive, making them less accessible, particularly in low-income regions or countries with limited healthcare budgets. This limits adoption to only the most severe cases and to hospitals that can afford the technology.

Requirement of Skilled Professionals:

ECMO procedures are complex and require specialized training for operation and monitoring. A shortage of trained ECMO technicians and specialists poses a significant challenge, as improper handling can lead to serious complications.

Risk of Complications:

ECMO therapy has associated risks, such as bleeding, infection, and clotting issues, which can deter its usage in certain patients or situations. These risks require close monitoring and increase the need for experienced healthcare staff.

Strict Regulatory Standards:

ECMO devices are subject to stringent regulations by authorities like the FDA, which requires extensive testing for safety and efficacy. These regulatory hurdles can delay product approvals and increase costs for manufacturers.

Limited Awareness and Accessibility in Developing Regions:

In emerging markets, awareness about ECMO technology and access to it are limited due to a lack of trained professionals and high treatment costs. This restricts the market potential in regions where the healthcare infrastructure is less developed.

Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.

LP Information, Inc. (LPI) ' newest research report, the “ECMO Devices Industry Forecast” looks at past sales and reviews total world ECMO Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected ECMO Devices sales for 2025 through 2031. With ECMO Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ECMO Devices industry.

This Insight Report provides a comprehensive analysis of the global ECMO Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ECMO Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ECMO Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ECMO Devices and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ECMO Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of ECMO Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO

Segmentation by End Users:
Adult
Neonatal
Pediatric

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Chinabridge(Shenzhen) Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global ECMO Devices market?

What factors are driving ECMO Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do ECMO Devices market opportunities vary by end market size?

How does ECMO Devices break out by Type, by End Users?

Please note: The report will take approximately 2 business days to prepare and deliver.